Company: ADPT
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001193125-25-103752
Chunk: 25

Company: Adaptive Biotechnologies Corp
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 25
---
 aggregate amount of compensation, including both the equity compensation and cash compensation, paid to any non-employeedirector in a calendar year will not exceed $750,000 for the first year of service and $600,000 for each year of service thereafter. PROPOSAL 1: ELECTION OF DIRECTORS Pursuant to our Articles of Incorporation and our Bylaws, the total number of directors constituting the board of directors is fixed from time to time by the board. The current authorized number of directors is fixed at six, which will automatically decrease to five following the Annual Meeting. The board of directors is divided into three classes, each containing as nearly as possible an equal number of directors. The current term of office of our Class III director expires at the Annual Meeting, while the term for our Class I directors expires at our 2026 annual meeting of shareholders and the term for our Class II directors expires at our 2027 annual meeting of shareholders. Based upon the recommendation of our nominating and corporate governance committee, the board has nominated Chad Robins, currently a Class III director, for election at the Annual Meeting. Michael Pellini’s term as a Class III director is expiring at our 2025 Annual Meeting, and Dr. Pellini is not being nominated for reelection. If elected at the Annual Meeting, Mr. Robins will serve a three-year term expiring at our 2028 annual meeting of shareholders and until his successor is duly elected and qualified as a Class III director, or until his earlier death, resignation or removal. At the Annual Meeting, proxies cannot be voted for a greater number of individuals than the nominee named in this proxy statement. 18

The board of directors and the nominating and corporate governance committee believe the skills, qualities, attributes and experience of our directors provide us with business acumen and a wide range of perspectives to engage each other and management to effectively address our evolving needs and represent the best interests of our shareholders.

If any nominee should become unavailable for election prior to the Annual Meeting, an event that currently is not anticipated, the proxies will be voted in favor of the election of a substitute nominee or nominees proposed by the board of directors or the number of directors may be reduced accordingly. Each nominee has agreed to serve if elected and the board of directors has no reason to believe that any nominee will be unable to serve.

We confirm as well that vacancies on the board, including any vacancy created by an increase in the size of the board, may be filled only by a majority of the directors